JOHN LOMBARD: Open Payments
NPI 1730897588 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 15 payments from 7 companies in 2025. Trend: 2023 $136 · 2024 $112 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Lilly USA, LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $16 |
| Corcept Therapeutics | 1 | $14 |
Products named: CAPLYTA, MOUNJARO, REXULTI, QULIPTA, VRAYLAR, Auvelity, Rybelsus, Korlym.
Industry payments across LA — which companies pay providers there.
